JNJ.... has not bottomed yet... C wave has just started... potential bottom at 144... and then potential for it to start 5th wave rally... we will see..not confident on this.
The world's largest health care company is about to get a little smaller. Johnson & Johnson recently told investors that it intends to spin off its consumer health products business into a separate new company.
If you've been considering these dividend-paying stocks for one reason or another, there's nothing wrong with the impending split. In fact, it makes the...
JNJ is finishing wave 3 that started in october of 2020 - Wave 1 started during the covid crash. Wave 3 is generally 1.618 extension the length of wave 1, placing the next target of growth to end at 241 dollars, roughly 45% growth. A good safe play for growth for your capital over the next 1-2 yrs.
The PEAD projected a Bullish outlook for $JNJ after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 88.89%.
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
Johnson & Johnson is a leader in several areas of pharmaceutical research, including oncology and immunologic diseases. The company's portfolio of drugs in these two areas brings in billions of dollars in revenue each quarter. The company is currently seeking to strengthen its market share in COVID-19 vaccines.
This year, Johnson & Johnson anticipates generating...
JNJ: Johnson & Johnson NYSE. NYSE:JNJ
support at $162.25; near target $167.45, Next $172 and then $180.
Net Income 2018-2020 3years in a row reach $14-15Billion!!!
Go Long!!! BOW Buy on Weakness
In a nutshell, Johnson & Johnson's third-quarter results were generally good. The company reported a 10.7% year-over-year increase in revenue to $23.3 billion. Adjusted earnings per share rose 18.2% to $2.60, well above the consensus estimate of $2.35.
Given the large earnings outperformance, you'd probably think the health care company's stock should have...
The prices of shares of pharmaceutical companies have dropped significantly since the beginning of autumn. Like many other stock market assets. Today, the Coronovirus situation is starting to worsen! The number of patients and deaths is increasing every day. And this is not surprising. Because the vacation season is over and the inhabitants of the whole planet...
From the way JNJ just broke through the closest support level and from the way that price hasn't been able to close beyond it again we expect JNJ to keep dropping until the next closest support level.
This Appears to be in the process of forming a Major Top after a very long uptrend, This could end up being a very large correction potentially cutting prices in half.
JOHNSON AND JOHNSON IN AVOID LIST....Stock already in daily time frame which already extended and may be entering in weekly timeframe Correction....SO may be Stock Expected to Trade in Range for next one year
In the 4 hour chart, we can see head and shoulders pattern which is now going to the last shoulder. Price has good support @162. Traced a Fibonacci to set my TP. Not financial advice!
I got this in meditation and Idk if it's a problem with their "vaccine" or what, but the sense is it'll be trending down. I also looked at the chart and it reminds me of a head and shoulders.
This is just posted as a journal.
